Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells-Reference-Cited by-同舟云学术

Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells

Published:2014-07-08 Issue:15 Volume:5 Page:6087-6101
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lee Yue-Zhi¹,Yang Cheng-Wei¹,Chang Hsin-Yu¹,Hsu Hsing-Yu¹,Chen Ih-Shen²,Chang Hsun-Shuo²,Lee Chih-Hao³,Lee Jinq-chyi¹,Kumar Chidambaram Ramesh¹,Qiu Ya-Qi¹⁴,Chao Yu-Sheng¹,Lee Shiow-Ju¹

Affiliation:

1. Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan

2. School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan

3. Department of Genetics and Complex Diseases, Division of Biological Sciences, Harvard School of Public Health, Boston, Massachusetts, USA

4. Graduate Program of Biotechnology in Medicine, Institute of Molecular & Cellular Biology, National Tsing Hua University, Hsinchu, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered expression of GLS2 indicates a poor prognosis and correlates with clinicopathological features of oral squamous cell carcinoma;International Journal of Oral and Maxillofacial Surgery;2024-08

2. Vitamin B12 inhibits peptidylarginine deiminases and ameliorates rheumatoid arthritis in CAIA mice;Biochemical and Biophysical Research Communications;2024-04

3. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment;Cell Communication and Signaling;2024-01-03

4. Glutaminase inhibition as potential cancer therapeutics: current status and future applications;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-12-11

5. Two Faces of Glutaminase GLS2 in Carcinogenesis;Cancers;2023-11-24